6833 — Sinco Pharmaceuticals Holdings Share Price
0.000.00%
Last trade - 00:00- HK$372.02m
- HK$416.96m
- CNY2.82bn
- 35
- 88
- 18
- 44
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.53 | ||
| Price to Tang. Book | 0.64 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.13 | ||
| EV to EBITDA | 2.96 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 17.28% | ||
| Return on Equity | 6.51% | ||
| Operating Margin | 4.1% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 2,049.8 | 2,024.06 | 2,271.51 | 2,540.06 | 2,821.32 | n/a | n/a | 19.12% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +401.29 | +11.34 | -56.03 | -39.08 | -0.72 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sinco Pharmaceuticals Holdings Ltd is an investment holding company primarily engaged in the provision of comprehensive marketing, promotion and channel management service for imported pharmaceutical products and medical devices. The Company operates three segments. The Sale of Imported Pharmaceutical Products segment engages in marketing, promotion, channel management activities for the sale of improved human plasma-based pharmaceuticals, antibiotics and other pharmaceuticals focused on therapeutic areas and complementary to human plasma-based products and other categories. The Research and Manufacturing of Aesthetic Medicine segment engages in the research and development and manufacturing of aesthetic medicine. The Medical Beauty Services segment engages in the provision of medical beauty services through its subsidiary company. The Company conducts its business in the domestic market.
Directors
- Xiangbin Huang CHM (49)
- Min Jin CCE (43)
- Yifan Li CFO (36)
- Zhizheng Li SVP (42)
- Guowei Liu VOP (39)
- Fei Peng CTR (42)
- Yue Wu DSL (36)
- Ling Bai OTH (36)
- Haibin Hu OTH (43)
- Xianghong Li OTH (31)
- Kin Wai Li SEC
- Yunlu Peng SEC (29)
- Zhizhong Bai NID (63)
- Ying Kit Lau NID (44)
- Wenfang Liu NID (82)
- Qing Wang NID (51)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 16th, 2015
- Public Since
- March 10th, 2016
- No. of Employees
- 291
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 2,032,890,585
- Address
- E5-1805, Global Center, No. 1700, CHENGDU
- Web
- https://www.sinco-pharm.com/zh-cn/
- Phone
- +86 2862912988
- Auditors
- CL Partners CPA Limited
Upcoming Events for 6833
Dividend For 6833.HK - 0.0020 HKD
Sinco Pharmaceuticals Holdings Ltd Annual Shareholders Meeting
Similar to 6833
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the Sinco Pharmaceuticals Holdings share price?
As of Today at 23:16 UTC, shares in Sinco Pharmaceuticals Holdings are trading at HK$0.19. This share price information is delayed by 15 minutes.
How has the Sinco Pharmaceuticals Holdings share price performed this year?
Shares in Sinco Pharmaceuticals Holdings last closed at HK$0.19 and the price had moved by -26% over the past 365 days. In terms of relative price strength the Sinco Pharmaceuticals Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -25.15% over the past year.
What are the analyst and broker recommendations for Sinco Pharmaceuticals Holdings?
There is no consensus recommendation for this security.
Find out moreWhat is the Sinco Pharmaceuticals Holdings dividend yield?
The Sinco Pharmaceuticals Holdings dividend yield is 1.08% based on the trailing twelve month period.
Does Sinco Pharmaceuticals Holdings pay a dividend?
Last year, Sinco Pharmaceuticals Holdings paid a total dividend of CNY0.00, and it currently has a trailing dividend yield of 1.08%.Looking ahead, shares in Sinco Pharmaceuticals Holdings are due to go ex-dividend on 2025-05-19 and the next dividend pay date is 2025-06-03.
When does Sinco Pharmaceuticals Holdings next pay dividends?
Sinco Pharmaceuticals Holdings are due to go ex-dividend on 2025-05-19 and the next dividend pay date is 2025-06-03. The historic dividend yield on Sinco Pharmaceuticals Holdings shares is currently 1.08%.
How do I buy Sinco Pharmaceuticals Holdings shares?
To buy shares in Sinco Pharmaceuticals Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sinco Pharmaceuticals Holdings?
As of the previous close price of HK$0.19, shares in Sinco Pharmaceuticals Holdings had a market capitalisation of HK$372.02m.
Where are Sinco Pharmaceuticals Holdings shares listed?
Here are the trading details for Sinco Pharmaceuticals Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 6833
What kind of share is Sinco Pharmaceuticals Holdings?
Based on an overall assessment of its quality, value and momentum Sinco Pharmaceuticals Holdings is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sinco Pharmaceuticals Holdings share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Sinco Pharmaceuticals Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sinco Pharmaceuticals Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -14.02%.
As of the last closing price of HK$0.19, shares in Sinco Pharmaceuticals Holdings were trading -13.94% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sinco Pharmaceuticals Holdings PE Ratio?
The Sinco Pharmaceuticals Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.19.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sinco Pharmaceuticals Holdings?
Sinco Pharmaceuticals Holdings' management team is headed by:
- Xiangbin Huang - CHM
- Min Jin - CCE
- Yifan Li - CFO
- Zhizheng Li - SVP
- Guowei Liu - VOP
- Fei Peng - CTR
- Yue Wu - DSL
- Ling Bai - OTH
- Haibin Hu - OTH
- Xianghong Li - OTH
- Kin Wai Li - SEC
- Yunlu Peng - SEC
- Zhizhong Bai - NID
- Ying Kit Lau - NID
- Wenfang Liu - NID
- Qing Wang - NID